From Setback to Comeback: Effective Solutions for Delayed Recovery
1 MIN READ
Learn how to effectively ignite workers' compensation recovery by addressing some of the biggest return-to-work obstacles, including mental health comorbidities, social factors, and delayed intervention. See how data-driven strategies lead to successful claims management and faster employee recovery.
Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
3 MIN READ
The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Nikki Wilson examines Journavx, a new FDA-approved nonopioid pain medication, and its potential impact on workers' compensation as a safer alternative to opioids for acute pain management.
Ask The Pharmacist: Buprenorphine’s Role in Workers’ Compensation Pain Management
3 MIN READ
Buprenorphine, a Schedule III controlled substance approved by the U.S. Food and Drug Administration (FDA), is increasingly being considered for pain management in workers' compensation cases. This partial opioid agonist offers a unique profile that balances effective pain relief with a lower risk of abuse and dependence compared to full opioid agonists.
Ask The Pharmacist: Asthma and Smoke Inhalation Treatments
5 MIN READ
Asthma is a common chronic respiratory disease that leads to difficulty breathing due to the presence of inflammation and bronchoconstriction. It’s often triggered by allergens, irritants or infections and in some occupational settings, employees may develop asthma or experience exacerbations because of airborne irritants, such as smoke or certain chemical agents (e.g., ash, pesticides, mineral dust, sawdust, etc.). The treatment of asthma focuses on controlling inflammation, preventing bronchospasm and minimizing exposure to environmental triggers.
Ask The Pharmacist: Preventing Tetanus in Workers’ Compensation
2 MIN READ
Tetanus is a serious infectious disease that can result from workplace injuries. Caused by spores of the bacterium Clostridium tetani, tetanus is often associated with rusty nails but these spores are found in many environments, including soil, dust and animal feces. All it takes for infection is a small cut, puncture wound, or scrape—common injuries in many workplaces.
Price Opportunist List and Smart PA Program Drive Decrease in Topical Utilization and Spend
2 MIN READ
Struggling with skyrocketing medication costs despite stable volumes? One workers’ compensation carrier reduced spending on dermatological/topical medications from $232k to $50k and eliminated them from their Top 10 spend categories. Discover how Enlyte’s innovative solutions made it possible.